go back

Myeloproliferative or Neoplasm Diagnoses (with MCC)

Missouri rates for MS-DRG 843

Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC

Rates data updated October 2026.

How much does Myeloproliferative or Neoplasm Diagnoses (with MCC) cost?

$23,988

Typical facility fee. In Missouri, October 2026.

Insurers have agreed to pay about $23,988 for this service. Most negotiated rates run $19,055 to $30,200.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 6 insurance carriers under federal price transparency rules.

How much rates vary

Facilitymedian $23,988 · 10th to 90th $16,218 to $38,019
$5K$10K$20K$50Kfacility $23,988

Distribution of negotiated rates across all payers (price axis is log-scale). Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
None
Typical Low
$15,488.17
Median
$21,877.62
Typical High
$26,302.68
Ambetter
Setting
Facility
Modifier
None
Typical Low
$15,848.93
Median
$18,197.01
Typical High
$37,153.52
Anthem BCBS
Setting
Facility
Modifier
None
Typical Low
$16,218.10
Median
$22,908.68
Typical High
$38,018.94
Cigna
Setting
Facility
Modifier
None
Typical Low
$19,952.62
Median
$26,302.68
Typical High
$38,904.51
Medica
Setting
Facility
Modifier
None
Typical Low
$12,022.64
Median
$24,547.09
Typical High
$39,810.72
United
Setting
Facility
Modifier
None
Typical Low
$12,022.64
Median
$25,703.96
Typical High
$35,481.34

Where Missouri sits

The same service costs 195.0 times more in Alaska than in Hawaii. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

Missouri· 38th of 51

$23,988

AK $53,703HI $275

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.